Arkolith/Insider Trading/SNTI/Form 4

Rajangam Kanya

Pres. & Chief Med. & Dev. Off.Senti Biosciences, Inc. (SNTI) · full profile →Form 4 · filed Feb 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2025Sell(S)182$4.37$7959K
Feb 4, 2025Sell(S)1K$4.07$5K9K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001854270-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML